Article
Prognostic Value of IGFBP6 in Breast Cancer: Focus on Glucometabolism
1 Jan 2024
Abstract excerpt
IGFBP6, a member of the IGF binding protein (IGFBP) family, is a specific inhibitor of insulin-like growth factor II (IGF-II) and can inhibit the growth of malignant tumors overexpressing IGF-II. Type 2 diabetes (T2D) is a basic disorder of glucose metabolism that can be regulated by IGF-related pathways. We performed bioinformatics analysis of the TCGA database to explore the possible mechanism of IGFBP6 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
